| Safety and Efficacy Study of Glufosfamide in Ovarian Cancer (NCT00442598) | Eleison Pharmaceuticals LLC. | 2007-01-01 |
| Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer (NCT00420381) | Eli Lilly and Company | 2007-01-01 |
| Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer (NCT00381888) | Masonic Cancer Center, University of Minnesota | 2007-01-01 |
| Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression. (NCT00408967) | EMD Serono | 2006-12-31 |
| Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors (NCT00432094) | Masonic Cancer Center, University of Minnesota | 2006-12-19 |
| Analyzing the Composition of Tears to Identify Cancer (NCT00574678) | University of Arkansas | 2006-12-01 |
| Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (NCT00418574) | Menarini Group | 2006-12-01 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer (NCT00436410) | National Institutes of Health Clinical Center (CC) | 2006-12-01 |
| T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer (NCT00900523) | Vanderbilt-Ingram Cancer Center | 2006-11-01 |
| Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") (NCT00391118) | Eli Lilly and Company | 2006-11-01 |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors (NCT00551122) | University of Southampton | 2006-11-01 |
| Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00407758) | Gynecologic Oncology Group | 2006-11-01 |
| Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-11-01 |
| A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy (NCT00883181) | Amgen | 2006-11-01 |
| A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing (NCT00381173) | Eisai Inc. | 2006-11-01 |
| Ovarian Cancer and Immune Response to Flu Vaccine (NCT00478387) | University of Pennsylvania | 2006-10-01 |
| Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer (NCT00400348) | CASI pharmaceuticals, Inc. | 2006-10-01 |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma (NCT00410462) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-10-01 |
| Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT00408070) | UConn Health | 2006-10-01 |
| OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer (NCT00382811) | MEI Pharma, Inc. | 2006-10-01 |
| ChemoFx® PRO - A Post-Market Data Collection Study (NCT00669422) | Precision Therapeutics | 2006-10-01 |
| Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer (NCT00390611) | SCRI Development Innovations, LLC | 2006-10-01 |
| Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy (NCT00377429) | Neovii Biotech | 2006-09-01 |
| Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma (NCT00418093) | Dana-Farber Cancer Institute | 2006-09-01 |
| Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy (NCT02349958) | Bay Area Gynecology Oncology | 2006-09-01 |
| Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer (NCT00368420) | AGO Study Group | 2006-09-01 |
| Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT00588237) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
| Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin (NCT00423852) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer (NCT00610740) | Masonic Cancer Center, University of Minnesota | 2006-07-01 |
| Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer (NCT00345540) | Cellectar Biosciences, Inc. | 2006-07-01 |
| Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer (NCT06385912) | Tongji Hospital | 2006-07-01 |
| Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens (NCT00610792) | Millennium Pharmaceuticals, Inc. | 2006-07-01 |
| Blood Test for Ovarian Cancer Associated Antibodies (CAAb) (NCT00327925) | Lab Discoveries Ltd. | 2006-07-01 |
| Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer (NCT00527631) | Heidelberg University | 2006-07-01 |
| Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01 (NCT00436774) | Children's Cancer and Leukaemia Group | 2006-06-01 |
| Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma (NCT00429559) | Hellenic Oncology Research Group | 2006-06-01 |
| Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers (NCT00343044) | Benaroya Research Institute | 2006-06-01 |
| Platinum-Resistant, Recurrent Epithelial Ovarian Cancer (NCT00484666) | Carilion Clinic | 2006-05-01 |
| Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324) | OHSU Knight Cancer Institute | 2006-05-01 |
| Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy (NCT00318370) | Morphotek | 2006-05-01 |
| Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00303888) | Yale University | 2006-05-01 |
| A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer (NCT00325494) | Morphotek | 2006-05-01 |
| Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00373217) | Craig L Slingluff, Jr | 2006-04-13 |
| Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin (NCT00369954) | Gynecologic Oncology Group | 2006-04-01 |
| Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer (NCT00322881) | Dana-Farber Cancer Institute | 2006-04-01 |
| Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function (NCT00525460) | Dana-Farber Cancer Institute | 2006-04-01 |
| Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers (NCT00319748) | Masonic Cancer Center, University of Minnesota | 2006-04-01 |
| Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00483782) | Medical Research Council | 2006-04-01 |
| TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary (NCT00296816) | Sanofi | 2006-03-01 |
| A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer (NCT00281632) | GlaxoSmithKline | 2006-03-01 |
| MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer (NCT00403429) | National Cancer Institute, Naples | 2006-03-01 |
| Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies (NCT00315861) | SCRI Development Innovations, LLC | 2006-03-01 |
| Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00897039) | Southeastern Gynecologic Oncology | 2006-03-01 |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer (NCT00601406) | The Christie NHS Foundation Trust | 2006-03-01 |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors (NCT00335491) | University of Utah | 2006-03-01 |
| Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer (NCT00383279) | Wake Forest University Health Sciences | 2006-02-01 |
| Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire (NCT00517621) | ARCAGY/ GINECO GROUP | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer (NCT00444054) | Albert Einstein College of Medicine | 2006-02-01 |
| A Phase I Study of ECO-4601 in Patients With Advanced Cancer (NCT00338026) | Thallion Pharmaceuticals | 2006-02-01 |
| Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer (NCT00445965) | Memorial Sloan Kettering Cancer Center | 2006-01-01 |
| Screening and Identification of Ovarian Cancers (NCT00854399) | National Taiwan University Hospital | 2006-01-01 |
| Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma (NCT02469116) | Washington University School of Medicine | 2006-01-01 |
| Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer. (NCT02298855) | University College, London | 2006-01-01 |
| Study of XL999 in Patients With Previously Treated Ovarian Cancer (NCT00277290) | Symphony Evolution, Inc. | 2006-01-01 |
| Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma (NCT00582205) | University of Oklahoma | 2006-01-01 |
| PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion (NCT00173407) | National Taiwan University Hospital | 2006-01-01 |
| Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer (NCT00354601) | Wake Forest University Health Sciences | 2006-01-01 |
| Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (NCT00648102) | Celldex Therapeutics | 2006-01-01 |
| Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors (NCT00303940) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study (NCT00323726) | New Mexico Cancer Research Alliance | 2005-12-01 |
| Risk of Ovarian Cancer in Patients With a Pelvic Mass (NCT00315692) | Fujirebio Diagnostics, Inc. | 2005-12-01 |
| A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer (NCT02004093) | Hoffmann-La Roche | 2005-12-01 |
| Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer (NCT00317434) | University of Alabama at Birmingham | 2005-11-01 |
| Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT00267696) | Ohio State University Comprehensive Cancer Center | 2005-11-01 |
| Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer (NCT00262990) | Novartis Pharmaceuticals | 2005-11-01 |
| Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma (NCT00179725) | Celgene Corporation | 2005-11-01 |
| Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer (NCT00466986) | Southeastern Gynecologic Oncology | 2005-11-01 |
| Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00331422) | Masonic Cancer Center, University of Minnesota | 2005-10-01 |
| Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) (NCT00239980) | Ontario Clinical Oncology Group (OCOG) | 2005-10-01 |
| Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass (NCT00238342) | Gynecologic Oncology Group | 2005-10-01 |
| Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. (NCT00287482) | Women and Infants Hospital of Rhode Island | 2005-10-01 |
| Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants (NCT00628654) | University of California, Davis | 2005-10-01 |
| Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma (NCT00758732) | Hellenic Oncology Research Group | 2005-10-01 |
| Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer (NCT00170677) | North Eastern German Society of Gynaecological Oncology | 2005-09-01 |
| Safety of Antioxidants During GYN Cancer Care (NCT00284427) | Jeanne Drisko, MD, CNS, FACN | 2005-09-01 |
| Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer (NCT00263822) | European Organisation for Research and Treatment of Cancer - EORTC | 2005-09-01 |
| Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients (NCT00268918) | Dana-Farber Cancer Institute | 2005-09-01 |
| Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer (NCT00230542) | Dana-Farber Cancer Institute | 2005-09-01 |
| Evaluating Tools for Health Promotion and Disease Prevention (NCT00164658) | Centers for Disease Control and Prevention | 2005-09-01 |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT01172028) | University of Arizona | 2005-09-01 |
| Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer (NCT00499512) | M.D. Anderson Cancer Center | 2005-08-10 |
| A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment (NCT00421889) | Valerio Therapeutics | 2005-08-01 |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors (NCT00433407) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients (NCT00478452) | University of Pennsylvania | 2005-08-01 |
| The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients (NCT00173394) | National Taiwan University Hospital | 2005-08-01 |
| Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant (NCT00321932) | University of Minnesota | 2005-07-01 |
| Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers (NCT00291473) | Ludwig Institute for Cancer Research | 2005-07-01 |